Centogene N.V. (NASDAQ:CNTGF) — Market Cap & Net Worth
Market Cap & Net Worth: Centogene N.V. (CNTGF)
Centogene N.V. (NASDAQ:CNTGF) has a market capitalization of $3.48 Million ($3.48 Million) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29325 globally and #5991 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Centogene N.V.'s stock price $0.12 by its total outstanding shares 29000137 (29.00 Million). Also see Centogene N.V. balance sheet assets for a full breakdown of the balance sheet.
Centogene N.V. Market Cap History: 2019 to 2026
Centogene N.V.'s market capitalization history from 2019 to 2026. Data shows change from $292.03 Million to $3.48 Million (-50.03% CAGR). Also see CNTGF operating cash flow for how efficiently the company converts equity into cash flow.
Centogene N.V. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Centogene N.V.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Centogene N.V. for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.72x
Centogene N.V.'s market cap is 0.72 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $312.62 Million | $38.45 Million | -$21.99 Million | 8.13x | N/A |
| 2021 | $151.61 Million | $42.23 Million | -$46.25 Million | 3.59x | N/A |
| 2022 | $26.97 Million | $47.47 Million | -$31.84 Million | 0.57x | N/A |
| 2023 | $34.80 Million | $48.54 Million | -$35.53 Million | 0.72x | N/A |
Competitor Companies of CNTGF by Market Capitalization
Companies near Centogene N.V. in the global market cap rankings as of September 17, 2026. Review tangible net worth ratio of Centogene N.V. to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Centogene N.V. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #163 globally with a market cap of $147.17 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #472 globally with a market cap of $57.08 Billion USD ( CN¥390.06 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $648.43 |
| #163 | Danaher Corporation | NYSE:DHR | $147.17 Billion | $208.36 |
| #472 | WuXi AppTec Co Ltd | SHG:603259 | $57.08 Billion | CN¥157.71 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $345.34 |
Centogene N.V. Historical Marketcap From 2019 to 2026
Between 2019 and today, Centogene N.V.'s market cap moved from $292.03 Million to $ 3.48 Million, with a yearly change of -50.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.48 Million | +14.29% |
| 2025 | $3.05 Million | -19.23% |
| 2024 | $3.77 Million | -89.17% |
| 2023 | $34.80 Million | +29.03% |
| 2022 | $26.97 Million | -82.21% |
| 2021 | $151.61 Million | -51.50% |
| 2020 | $312.62 Million | +7.05% |
| 2019 | $292.03 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Centogene N.V. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.48 Million USD |
| MoneyControl | $3.48 Million USD |
| MarketWatch | $3.48 Million USD |
| marketcap.company | $3.48 Million USD |
| Reuters | $3.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Centogene N.V.
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA … Read more